Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial

Autor: Han, Bihua, Song, Yufei, Li, Changgui, Yang, Wanqi, Ma, Qingxia, Jiang, Zhiwei, Li, Minjie, Lian, Xiaojuan, Jiao, Wenbin, Wang, Lei, Shu, Qun, Wu, Zhiwei, Zhao, Yuliang, Li, Qi, Gao, Qiang ^*

Publikováno v: In The Lancet Infectious Diseases December 2021 21(12):1645-1653

Long-Lasting Virus-Specific T Cell Response with Divergent Features in Self-Resolved and Chronic Hepatitis C Virus Patients 35 Years Postinfection.

Autor: Ji W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Zhao M; Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China., Zhou J; Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang, China; and., Zheng H; Shijiazhuang Fifth Hospital, Shijiazhuang, China., Li N; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Han B; Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang, China; and., Yin W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Bi S; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Gao GF; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China; liujun@ivdc.chinacdc.cn zycdchp@sina.com gaofu@chinacdc.cn.; Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China., Zhang Y; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China; liujun@ivdc.chinacdc.cn zycdchp@sina.com gaofu@chinacdc.cn., Liu WJ; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China; liujun@ivdc.chinacdc.cn zycdchp@sina.com gaofu@chinacdc.cn.

Publikováno v: ImmunoHorizons [Immunohorizons] 2022 Mar 07; Vol. 6 (3), pp. 191-201. Date of Electronic Publication: 2022 Mar 07.